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a b s t r a c t
Vpr and Vpx are primate lentivirus proteins that manipulate the cellular CRL4 ubiquitin ligase complex.
While Vpr is common to all primate lentiviruses, Vpx is only encoded by HIV-2 and a limited range of
SIVs. Although Vpr and Vpx share a high degree of homology they are known to induce markedly
different effects in host cell biology through the recruitment of different substrates to CRL4. Here we
explore the interaction of HIV-1 Vpr and SIVmac Vpx with the CRL4 substrate receptor DCAF1. Through
mutational analysis of DCAF1 we demonstrate that although Vpr and Vpx share a highly similar DCAF1-
binding motif, they interact with a different set of residues in DCAF1. In addition, we show that Vpx
recruits SAMHD1 through a protein–protein interface that includes interactions of SAMHD1 with both
Vpx and DCAF1, as was ﬁrst suggested in crystallography data by (Schwefel, D., Groom, H.C.T., Boucherit,
V.C., Christodoulou, E., Walker, P.A., Stoye, J.P., Bishop, K.N., Taylor, I.A., 2014. Structural basis of lentiviral
subversion of a cellular protein degradation pathway., Nature, 505, 234–238).
& 2014 Elsevier Inc. All rights reserved.
Introduction
Many viruses encode proteins that manipulate the cellular
ubiquitin proteasome system (UPS) to degrade cellular restriction
factors. Human Immunodeﬁciency Virus type-1 (HIV-1) encodes
three such proteins (Vif, Vpu, and Vpr). In addition, some primate
lentiviruses (including HIV-2 and SIVmac) encode the Vpr paralog,
Vpx. While the mechanism of UPS manipulation and the cellular
targets of Vif and Vpu have been well characterized, the functions
of Vpr and Vpx have been more difﬁcult to elucidate (reviewed in
Guenzel et al. (2014), Malim and Emerman (2008) and Romani and
Cohen (2012)). In 2011, two groups independently identiﬁed
SAMHD1 as the cellular protein targeted by Vpx (Hrecka et al.,
2011; Laguette et al., 2011). More recently, Laguette et al. (2014)
proposed that Vpr activates the SLX4 complex in a ubiquitin
dependent manner.
Vpr is a short, 96-amino acid protein that is highly conserved
among primate lentiviruses, which is expressed late during viral
replication and is present in virions (Cohen et al., 1990; Müller
et al., 2000). Vpr and its function appear to be crucial for HIV
infection as no primary isolates have been described which lack
Vpr (reviewed in Andersen et al. (2008)). While Vpr induces cell-
cycle arrest at the G2/M transition through the activation of the
DNA damage sensor Ataxia Telangiectasia and Rad3-related pro-
tein (ATR) (Roshal et al., 2003), the signiﬁcance of this cell cycle
arrest in the virus life cycle remains unclear (reviewed in
Andersen et al. (2008)). Recently, it was proposed that G2 arrest
is initiated by the Vpr-mediated activation of the SLX4, presum-
ably generating aberrant damage to the host genome and activa-
tion of the cellular DNA damage response (Laguette et al., 2014).
In 1994, Vpr was shown to interact with a novel cellular protein
(Zhao et al., 1994), subsequently named DDB1-Cullin 4-Associated
Factor 1 (DCAF1). The signiﬁcance of this interaction remained
uncertain until DCAF1 was identiﬁed as a substrate receptor for
the Cullin 4-RING E3 ligase (CRL4) (Angers et al., 2006; He et al.,
2006; Higa et al., 2006; Jin et al., 2006). Subsequent studies
demonstrated that induction of G2 arrest by Vpr was dependent
on the manipulation of CRL4DCAF1 (Belzile et al., 2007; Dehart et al.,
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2007; Hrecka et al., 2007; Le Rouzic et al., 2007; Schröfelbauer
et al., 2007; Tan et al., 2007; Wen et al., 2007).
In addition to Vpr, some primate lentiviral lineages encode the
Vpr paralog, Vpx. Early studies identiﬁed a role for Vpx in the
infection of myeloid lineage cells, dendritic cells and macrophages,
by overcoming a block to viral reverse transcription (Yu et al.,
1991; Goujon et al., 2008). Similar to Vpr, the Skowronski and
Stevenson laboratories demonstrated that this Vpx-mediated
effect requires the formation of a Vpx-CRL4DCAF1 complex
(Sharova et al., 2008; Srivastava et al., 2008). In 2011, SAMHD1
was identiﬁed as the cellular protein targeted by Vpx, in the
context of CRL4DCAF1 (Hrecka et al., 2011; Laguette et al., 2011).
Thus far, three mechanisms for viral directed ubiquitination of
cellular proteins have been observed: 1) the encoding of a viral E3
ubiquitin ligase, as is the case of the ICP0 protein of Herpes
Simplex 1 (Boutell et al., 2002; Everett, 2000); 2) the replacement
of the substrate receptor of a cellular ubiquitin ligase by a virally
encoded protein, as is the case of protein V from SV5 (Horvath,
2004) and Vif from primate lentiviruses (Mehle et al., 2004;
Sheehy et al., 2003; Yu et al., 2003); and 3) mimicry of an
endogenous substrate by the viral protein, which then ferries a
cellular protein to be targeted for ubiquitination, as observed in
the manipulation of CRL1βTRCP by HIV-1 Vpu to target CD4 (Bour
et al., 2001; Margottin et al., 1998).
In this study we investigated the manner in which HIV-1 Vpr
and SIVmac Vpx (hereafter referred to as “Vpr” and “Vpx”,
respectively) interact with DCAF1 resulting in the alteration of
substrate speciﬁcity of CRL4DCAF1. Using mutational analysis of the
DCAF1 substrate-binding interface we found that although Vpr
and Vpx share a highly homologous DCAF1-binding motif on their
third alpha helix, Vpr and Vpx interact with CRL4DCAF1 using
different residues on DCAF1. In addition, we identiﬁed the DCAF1
residues, D1092 which, when mutated, disrupted SAMHD1 degra-
dation without impeding Vpx binding. Therefore, we surmise that
the recruitment of SAMHD1 to DCAF1 by Vpx is mediated by a
combination of residues in Vpx and DCAF1. Our results conﬁrm
and expand on a functional level the intermolecular interactions
that were previously identiﬁed by Schwefel et al. (2014) via a co-
crystal that included the DCAF1 WD40 domain, the C-terminal
domain of SAMHD1 and Vpx.
Materials and methods
Cell culture
Exponentially growing 293FT cells were cultured in Dulbecco
minimal essential medium (DMEM; Invitrogen, Carlsbad, CA) sup-
plemented with 10% fetal bovine serum (FBS) and 1% L-glutamine
(Invitrogen). 293FT cells were transfected using the Calcium Phos-
phate method, as previously described (Zhu et al., 2001). Cells were
harvested 36 h post-transfection, washed 2x with Phosphate Buf-
fered Saline (PBS) and lysed as described below.
Plasmids
DCAF1 Iso1 cDNA (NCBI accession NM_014703) was ampliﬁed by
PCR from a human cDNA library with the addition of an N-terminal
3x FLAGs-poly linker, then assembled into pCMV.Sport 6 (Invitro-
gen, Carlsbad, CA). DCAF1 truncations were made by generating
unique restrictions sites which were indicated (Fig. 1A) using
Quikchange Lightning site-directed mutagenesis (Agilent Technol-
ogies, Santa Clara, CA). DCAF1 WD40 point mutants were also
generated via Quikchange. Myc-huSAMHD1 was purchased from
OriGene (Rockville, MD). pcDNA3.1 was purchased from Invitrogen.
HA-Vpr of HIV-1 and HA-Vpx of SIVmac were subcloned from
pHR-HA-Vpr-IRES-GFP and pHR-HA-Vpx-IRES-GFP, respectively
(Dehart et al., 2007) into pFIN-EF1-GFP-2a-mCherH-WPRE (a kind
gift of Dr. Semple-Rowland) (Verrier et al., 2011) in substitution of
the mCherry gene.
Immunoprecipitation and Western blots
For immunoprecipitation, cells were gently detached by incubation
in PBS, pelleted and lysed with FLAG IP buffer (50 mM Tris HCI, pH 7.4,
15 0 mM NaCl, 1 mM EDTA and 1% TRITON X-100) in the presence of
protease inhibitors (Complete EDTA free tablets; Roche, Indianapolis,
IN). Lysate protein concentrations were determined by Pierce™ BCA
(Thermo Scientiﬁc, Rockford, IL) and brought to equal protein con-
centration. Lysates were subjected to immunoprecipitation using Anti-
FLAGs M2 Magnetic Beads (SIGMA-ALDRICH, St. Louis, MO). Brieﬂy,
lysates were incubated with beads for 2 h (at RT) to overnight (at 4 1C).
Beads were washed 5x with lysis buffer and proteins eluted with 3x-
FLAGs Peptide, 100 mg/ml, for 1 h at RT. Cells used in degradation
assays were lysed in SET Buffer (1% SDS, 50 mM Tris HCL, pH 7.4, 1 mM
EDTA); lysates were thoroughly denatured by boiling for 5 min.
Lysates and immunoprecipitation samples were resolved by SDS-
PAGE on 4–10% Criteron™ TGX™ gels (Bio Rad, Hercules, CA) as per
manufacturer's recommendations and transferred to PVDF membrane
(EMD Millipore, Billerica, MA). The following antibodies were used:
Fig. 1. The WD40 domain of DCAF1 is necessary for interaction with DDB1. (A) Domain
architecture of WT DCAF1 (Isoform 1) and truncations. (B) 293FT cells were transfected
with plasmids expressing FLAG-DCAF1 or the truncations described in (A). 36 h post-
transfection cell lysates were subject to FLAG-immunoprecipitation (DCAF1) and
analyzed for the presence of DDB1 by Western blot.
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FLAGsM2 and β-actin (Sigma-Aldrich), HA.11 and 9E11(c-Myc)(Cov-
ance), and DDB1 and VprBP/DCAF1 (Abcam).
DCAF1 depletion
DCAF1 was knockdown using an shRNA expression plasmid
previously described (Ward et al., 2009). Brieﬂy, 293FT cells were
transfected as described above with FG12 DCAF1_3590 and FG12
DCAF1_Scambled vectors graciously provided by Dr. Edward
Barker (Rush University Medical Center, Chicago, Illinois).
DCAF1_3590 target and scrambled sequences were previously
described (Hrecka et al., 2007; Ward et al., 2009). Transfected
cells were analyzed for DCAF1 depletions 48 h later by Western
blot using rabbit anti-DCAF1 (Abcam).
Results and discussion
DCAF1 interacts with DDB1 through a region N-terminal of the WD40
domain
Most DCAFs consist primarily of a WD40 domain (Higa et al.,
2006), a highly conserved β-propeller structure involved in med-
iating protein–protein interactions (Stirnimann et al., 2010). In
contrast, DCAF1 has a complex domain architecture, comprised of
an N-terminal armadillo domain (“Arm”), a central LisH domain, a
WD40 domain and a highly acidic C-terminal tail (Jin et al., 2006)
(Fig. 1A, isoform 1). Several groups have previously shown that Vpr
and Vpx interact with the DCAF1 WD40 domain (Gérard et al.,
2014; Le Rouzic et al., 2007; Schwefel et al., 2014). Whether the
other domains are required for viral proteins to alter substrate
speciﬁcity remains unknown. In order to better understand how
Vpx manipulates the CRL4DCAF1 ubiquitin ligase, we generated a
number of FLAG-tagged DCAF1 constructs in which each domain
was removed individually or in conjunction with others. We also
generated a construct reﬂecting the structure of the annotated
DCAF1 isoform 3 (Uniprot identiﬁer Q9Y4B6-3), which is char-
acterized by a large truncation within the Arm domain (Fig. 1A).
DCAF1-mediated substrate ubiquitination is dependent on the
interaction of DCAF1 with the ubiquitin ligase backbone com-
prised of DDB1-Cullin 4-Roc1 (Angers et al., 2006; Hu et al., 2004).
To determine the minimal DCAF1 construct capable of interacting
with DDB1, we performed immunoprecipitation studies. 293FT
cells were transfected with expression vectors encoding the
indicated DCAF1 truncations, subjected to FLAG immunoprecipita-
tion and analyzed for the presence of DDB1. As expected, full
length DCAF1, both isoform 1 (“WT”) and isoform 3, were capable
of interacting with DDB1 (Fig. 1B, lanes 2 and 3). Consistent with
previous observations indicating a role of the WD40 domain in
DDB1 interaction (Angers et al., 2006), constructs lacking the
WD40 domain lost the ability to interact with DDB1 (Fig. 1B, lanes
4, 6–8). Surprisingly, the FLAG-DCAF1 WD40 construct did not
interact with DDB1 (Fig. 1B, lane 11). This is in contrast to earlier
reports in which the WD40 domain by itself was shown to be able
to interact with DDB1 (Gérard et al., 2014; Le Rouzic et al., 2007).
Most likely this discrepancy is due to differences in residues
spanned by the constructs used in these different studies (residues
1041–1377 (Le Rouzic et al., 2007); 1041–1393 (Gérard et al.,
2014); and 1073–1396 in this study). Interaction between DCAFs
and DDB1 is facilitated by a cryptic α-helix located N-terminal to
the WD40 domain, termed an Hbox (Li et al., 2009). Gérard et al.
(2014) recently determined that the putative DCAF1 Hbox spans
residues 1049–1062, a stretch of residues which is absent from our
WD40 construct. In agreement with this hypothesis the minimal
truncation we generated of DCAF1 was capable of interacting with
DDB1 containing the LisH and WD40 domains (Fig. 1B, lane 9). The
Δ-acidic DCAF1 construct was unable to interact with DDB1
(Fig. 1B, lane 5). This was a surprising result in view of the
observation that the construct containing LisH-WD40 domains
was sufﬁcient to bind to DDB1. The simplest explanation for these
observations would be that Δ-acidic DCAF1 construct is incorrectly
folded and lost the ability to bind to DDB1 even though all the
necessary domains may be present.
Mutations in the predicted DCAF1 WD40 substrate interface disrupt
Vpx-mediated SAMHD1 degradation
We then tested the DCAF1 LisH-WD40 and WD40 constructs
for their ability to facilitate SAMHD1 degradation by Vpx. To
determine the residues necessary for SIVmac Vpx to manipulate
the substrate speciﬁcity of DCAF1, we also generated a number of
point mutations in the WD40 domain of DCAF1 (Table 1). Sub-
strate binding to WD40 domains is typically mediated by polar
interactions on the “top” side (by convention) of the β-propeller
structure (Patel et al., 2008; Pons et al., 2008). Previous reports
have demonstrated that the top of WD40 domains form a shallow
groove that mediates interactions with proteins to be targeted for
ubiquitination (reviewed in Stirnimann et al. (2010) and Trievel
and Shilatifard (2009)). We utilized two independent methods to
Table 1
Summary of DCAF1 mutants. DCAF1 mutations were screened for their ability to
facilate Vpx-mediated SAMHD1 degradation or interact with DDB1, Vpx and Vpr as
indicated. “þ” indicates that SAMHD1 degradation was observed in the presence of
the DCAF1 construct or the DCAF1 construct was able to interact with indicated
protein. “” denotes that SAMHD1 degradation was not observed in the presences
of the DCAF1 construct or the DCAF1 construct was unable to co-IP the indicated
protein. The two constructs for which SAMHD1 degradation was observed to be
intermediated are denoted with “þ/”. ND indicates that the DCAF1 construct was
not tested for the indicated activity.
Function Interaction
SAMHD1 Deg Vpx Vpr DDB1
Iso1 þ þ þ þ
Iso3 ND ND ND þ
ΔWD40 ND ND ND 
ΔAcid ND ND ND 
ΔWD40-ΔAcid ND ND ND 
Arm-Iso1 ND ND ND 
Arm-Iso3 ND ND ND 
Lish-WD40  þ þ þ
ΔArm ND ND ND þ
WD40   þ 
WD40-Acid ND ND ND 
Acid ND ND ND 
ΔLish ND ND ND 
D1092A  þ þ þ
H1134A þ þ þ þ
N1135A þ/  þ þ
T1141A þ ND þ ND
T1155A þ ND þ ND
W1156H   þ þ
E1178A-D1179A þ ND þ ND
H1180A þ ND þ ND
K1196A þ ND þ ND
N1221A-N1222A þ ND þ ND
R1225A þ ND þ ND
N1226A þ ND þ ND
D1256A þ þ þ þ
K1257A þ ND þ ND
S1263A þ ND ND ND
D1295A þ ND ND ND
Q1296A þ ND þ ND
Q1316A þ ND þ ND
D1320A þ ND ND ND
F1334Y þ ND þ ND
V1350T þ ND þ ND
N1379A þ ND ND ND
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select a number of polar/charged residues, which we predicted
may be involved in binding to Vpx based on their predicted
location within the top face of DCAF1 WD40 domain: 1) homology
modeling between DCAF1 and the most closely related DCAF with
a known crystal structure (WDR5; Fig. 2A) (Patel et al., 2008;
Schuetz et al., 2006; Song and Kingston, 2008) by alignment of
primary sequences using ClustalW2 (Larkin et al., 2007) and 2) an
in silico (ModBase) structural prediction of the DCAF1 WD40
domain (Pieper et al., 2014). Selected residues were then mutated
to alanine. In addition, three hydrophobic residues (W1156, F1334
and V1350) were mutated, to polar amino acids of similar size,
based on their predicted proximity to and orientation towards the
Fig. 2. Analysis of DCAF1 mutations for their ability to facilitate Vpx-mediated SAMHD1 degradation. (A) DCAF1 WD40 domain and WDR5 protein sequences were aligned
and used to predict DCAF1 WD40 secondary structure. WDR5 tertiary structure is indicated below (bold lines – β-sheets, narrow lines connect β-sheets which form
respective “blades” of the β-propeller. Homology is indicated below: asterisks (n) indicate identity, colons (:) and periods (.), similarity. Arrowheads indicate residues mutated
in DCAF1. Residues observed to be important for Vpx mediated SAMHD1 degradation are indicted with a pound symbol (#) above the arrowhead. B) DCAF1 WD40 domain as
determined by Schwefel et al. (2014) (PDB accession 4CC9). The side chains for the three loss-of function mutants (D1092, N1135 and W1156) are shown in red, and those for
two control mutants (H1134 and D1256) are shown in cyan, additional residues screened are shown without side chains in purple. (C) 293FT cells were transfected with
human Myc-SAMHD1, HA-Vpx and/or FLAG-DCAF1 mutants. 36 h post-transfection, cells were lysed and analyzed for the presence of SAMHD1 by Western blot. (D) FLAG-
DCAF1 constructs were tested for the ability to facilitate Vpx-mediated degradation Myc-SAMHD1 in DCAF1 depleted 293FT cells. (E) Transfection of DCAF1 shRNA
expression construct efﬁciently depleted DCAF1 in 293FT cells.
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predicted substrate-binding groove. Finally, based on the recent
observations by Schwefel et al., we mutated residue D1092 in
order to functionally test its role in SAMHD1 recruitment by Vpx
(Schwefel et al., 2014). Mutated residues are represented as
arrowheads in Fig. 2A and colored (other than green) residues in
Fig. 2C.
293FT cells were transfected with DCAF1 expression constructs,
SAMHD1 and Vpx as indicated. Because endogenous DCAF1 was
not depleted in this experiment, this method evaluated the
abilities of indicated constructs to dominantly inhibit degradation
of SAMHD1. 36 h post-transfection cells were lysed and SAMHD1
degradation was analyzed by Western blot. As LisH-WD40 or
WD40 (Fig. 2C, lanes 8 and 9) constructs were unable to mediate
SAMHD1 degradation we propose that DCAF1 does not merely
serve as a bridge by which Vpx brings SAMHD1 to the CRL4DCAF1
ubiquitin ligase. Rather, additional domains of DCAF1 appear to be
necessary to facilitate this activity.
Two DCAF1 point mutants (D1092A, and W1156H) were
identiﬁed which failed to mediate the degradation of SAMHD1 in
the presence of Vpx while a third point mutant (N1135A) showed
reduced ability to facilitate SAMHD1 degradation by Vpx (Fig. 2C,
lanes 10, 12–13). Other point mutants (H1134A and D1256A) in the
DCAF1 WD40 domain (Fig. 2C, lanes 11 and 14), as well as all
additional point mutations in the DCAF1 WD40 domain (Table 1)
retained the ability to support Vpx-induced degradation of
SAMHD1. For simplicity, data corresponding to the three loss-of-
function mutants (side chains shown in red in Fig. 2B), as well as
two control mutants (side chains shown in cyan in Fig. 2B), are
shown and the overall results for all mutants are summarized in
Table 1.
In order to conﬁrm these results in the absence of potential
contribution of endogenous DCAF1 to the degradation of SAMHD1,
293FT cells were co-transfected with a DCAF1 shRNA expressing
plasmid, Myc-SAMHD1, FLAG-DCAF1 constructs and HA-Vpx as
indicated. FLAG-DCAF1 constructs were protected from shRNA
depletion by the generation of silent mutations at the shRNA-
targeting site. 48 h post-transfection, cells were lysed and ana-
lyzed for SAMHD1 degradation by Western blot (Fig. 2D–E). As
expected, Vpx was unable to facilitate the degradation of SAMHD1
in the absence of endogenous DCAF1 while the expression of WT
DCAF1 was able to restore Vpx mediated SAMHD1 degradation
(Fig. 2D lane 5 vs. 6). Conﬁrming the observations depicted in
Fig. 2C, DCAF1 W1156H was unable to elicit the degradation of
SAMHD1 and DCAF1 N1135A exhibited an intermediate phenotype
(Fig. 2D, lanes 9 and 8, respectively). The mutant DCAF1 H1134A
was able to recover Vpx mediated SAMHD1 degradation in DCAF1-
depleted cells (Fig. 2D lane 7). The efﬁciency of DCAF1 depletion
by shRNA is shown in Fig. 2E.
Select DCAF1 WD40 domain mutations disrupt Vpx binding
To better understand how the above DCAF1 truncations/sub-
stitutions (LisH-WD40, WD40, D1092A, H1134A, N1135A, W1156H
and D1256A) disrupt Vpx function, we analyzed the ability of each
to interact with Vpx by co-IP. As expected, immunoprecipitation of
full-length FLAG-DCAF1 was able to co-precipitate Vpx (Fig. 3, lane
4). Interestingly, in contrast to previous reports regarding the
highly related lentiviral protein HIV-1 Vpr (Le Rouzic et al. (2007)
and this report), the WD40 domain of DCAF1, alone, was not
sufﬁcient to co-IP with Vpx (Fig. 3, lane 5), while the longer
construct containing both LisH and WD40 domains retained this
function (Fig. 3, lane 6). These observations suggest that the Vpx–
DCAF1 interaction may involve residues outside the WD40 region
in addition to those within. Alternatively, it is also possible that the
presence of the LisH domain is required for the WD40 domain to
retain its native conformation.
While DCAF1 mutations D1092A, N1135A and W1156H all dis-
rupted Vpx-mediated SAMHD1 degradation, only N1135A and
W1156H (Fig. 3, lanes 9 and 10) resulted in a loss of Vpx interaction.
Residue D1092 in DCAF1 was recently shown to form a direct ionic
interaction with residue K622 of SAMHD1 (Schwefel et al., 2014). This
is consistent with our observation that DCAF1 D1092Awas still able to
bind to Vpx (Fig. 3, lane 7) but not to facilitate the degradation
SAMHD1. Therefore, our results functionally conﬁrm and extend the
ﬁndings by Schwefel et al. (2014) and suggest that the interaction of
Vpx with DCAF1 leads to the formation of a new protein–protein
interface that recruits SAMHD1 via interactions with both DCAF1 and
Vpx residues (Fig. 4). These observations taken together functional
conﬁrm the crystallographic data of Schwefel et al. demonstrating the
importance of residues N1135 and W1156 in binding the Vpx Q76
residue.
Vpr interacts with different residues in DCAF1 than those utilized
by Vpx
While a recently published crystallographic study identiﬁed the
Vpx–DCAF1 binding interface (Schwefel et al., 2014), no structural data
exists regarding the Vpr–DCAF1 interaction. The existence of a high
degree of homology between HIV-1 Vpr and SIVmac Vpx led us to
hypothesize that both viral proteins would interact with DCAF1 in a
similar manner. We speculated that the same set of residues in DCAF1
might mediate interactions with both viral proteins. In support of this
hypothesis, analogous mutations in the third helix of both Vpr (Q65R)
and Vpx (Q76R) have been shown to abrogate interaction with DCAF1
(Belzile et al., 2007; Dehart et al., 2007; Le Rouzic et al., 2007;
Schröfelbauer et al., 2007; Srivastava et al., 2008).
In order to examine the molecular interaction between DCAF1
and Vpr, we tested our panel of DCAF1 truncations and point
mutants for their ability to interact with Vpr. As a positive control,
wild-type Vpr was able to co-IP with FLAG-DCAF1 (Fig. 5A, lane 4).
In agreement with previous observations (Le Rouzic et al., 2007)
the DCAF1 WD40 domain alone was sufﬁcient to mediate Vpr
binding (Fig. 5A, lane 5). The longer LisH-WD40-containing con-
struct also retained Vpr binding (Fig. 5A, lane 6). In contrast to
what we observed with Vpx, both N1135A and W1156H DCAF1
substitutions retained Vpr binding (Fig. 5A, lanes 9 and 10).
Fig. 3. DCAF1 mutations differentially effect interaction with Vpx. 293FT cells were
transfected with plasmids expressing FLAG-DCAF1 or mutants and HA-Vpx as
indicated. Cell lysates were subject to FLAG-immunoprecipitation and analyzed for
the presence of HA-Vpx by Western blot.
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Therefore residues N1135 and W1156 are required for interaction
of DCAF1 with Vpx but not with Vpr. We conclude that Vpr and
Vpx interact with a non-identical set of residues in DCAF1 WD40
domain.
A previous study by Gérard et al. (2014) explored the interac-
tion between DCAF1 and HIV-1 Vpr by investigating the potential
role of F/YxxF/Y motifs within the DCAF1 WD40 domain, reminis-
cent of the motif identiﬁed in UNG2 as being necessary for Vpr
interaction (BouHamdan et al., 1998). However, mutation of these
motifs individually failed to identify residues of DCAF1 which
interact with Vpr (Gérard et al., 2014). The generation of a DCAF1–
Vpr co-crystal will be of great interest in order to more clearly
resolve the molecular nature of this interaction and its differences
in comparison to that of the DCAF1–Vpx complex.
Vpr and Vpx interact with DCAF1 in a competitive manner with each
other
The above results indicate that the binding surfaces for Vpx and
Vpr on DCAF1 are at least somewhat different. However, because none
of the WD40 domain point mutants tested disrupted Vpr binding
(data summarized in Table 1), we are unable to discern whether Vpx
and Vpr bind to overlapping or non-overlapping regions on the WD40
domain. To test whether the binding regions may overlap, we
designed the following competition experiment. We hypothesized
that if the Vpr and Vpx binding regions on DCAF1 overlap, then over-
expression of Vpr would to some degree interfere with the ability of
Vpx to recruit SAMHD1 to the ubiquitin ligase complex and would
therefore hinder SAMHD1 degradation. 293FT cells were transfected
with HA-Vpx alone or in combination with HA-Vpr at 1:2 or 1:1 Vpx:
Vpr expression plasmid ratios. As expected, Vpx expression resulted in
the depletion of SAMHD1 (Fig. 6, lane 1 vs. lane 2). Co-expression of
Vpr robustly inhibited Vpx induced SAMHD1 degradation at both
ratios (Fig. 6, lanes 3 and 4 vs. lane 2). Therefore, although we were
unable to deﬁne speciﬁc residues on DCAF1 that mediate interaction
with Vpr, the ability of Vpr to interfere with Vpx function suggest that
both viral proteins bind to overlapping areas within the top face of the
DCAF1 WD40. However, these results, cannot distinguish whether this
competition is for a shared/overlapping binding site of Vpr and Vpx or
if this competition is due to conformational changes in DCAF1 induced
by Vpr binding that may in turn disrupt Vpx binding at a distance.
Based on the high homology between their third α-helices, we favor a
model in which HIV-1 Vpr and SIVmac Vpx utilize a similar, but not
identical, binding interface on DCAF1 (Le Rouzic et al., 2007; Schwefel
et al., 2014; Srivastava et al., 2008) (reviewed in Morellet et al. (2009)).
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Fig. 4. Model of Vpx manipulation of the CRL4DCAF1 ubiquitin ligase. Interaction of
DCAF1 WD40 domain with Vpx is mediated primarily by interactions between
DCAF1 N1135 and W1156 and Vpx (red lines). Interaction between Q76 of Vpx with
residues N1135 and W1156 in DCAF1 was documented by Schwefel et al. (2014). In
addition, mutation of DCAF1 D1092 was observed to disrupt the ability of Vpx to
mediated SAMHD1 degradation without affecting binding to Vpx. D1092 was
recently shown to form an ionic bond with SAMHD1 K622 by Schwefel et al.
(2014) (orange line). Finally, based on previous reports interactions between Vpx
and SAMHD1 are known to involve multiple residues within the unstructured N-
terminus and linker between second and third α-helix of Vpx and SAMHD1 (blue
lines) (Schwefel et al., 2014).
Fig. 5. DCAF1 residues required for Vpr interaction differ from those required for
Vpx interaction. Plasmids expressing FLAG-DCAF1 or mutants and HA-Vpr were
transfected into 293FT cells. FLAG-DCAF1 was then immunoprecipitated and
analyzed for the presence of HA-Vpr by Western blot.
Fig. 6. Vpr is dominant over Vpx mediated SAMHD1 degradation. 293FT cells were
transfected with a HA-Vpx plasmid in the absence or presence of increasing
concentrations of HA-Vpr. All cells were transfected with equal amounts of total
plasmid DNA by transfection of pcDNA3.1. Cells were lysed 36 h post-transfection
and endogenous SAMHD1 levels were analyzed by Western blot.
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